Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

NCT06174402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

NCT06591455 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Use of Fenofibrate for Primary Biliary Cirrhosis

NCT00575042 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

NCT02965911 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)

NCT04047160 ·Status: COMPLETED ·Phase: PHASE1

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

NCT02823366 ·Status: UNKNOWN ·Phase: PHASE3

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

NCT02823353 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NCT02932449 ·Status: COMPLETED

Pilot Study of Fenofibrate for PSC

NCT01142323 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Pilot Study of FFP104 Dose Escalation in PBC Subjects

NCT02193360 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

NCT07296458 ·Status: RECRUITING ·Phase: PHASE3

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

NCT02516605 ·Status: COMPLETED ·Phase: PHASE2

Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

NCT04618575 ·Status: UNKNOWN ·Phase: PHASE4

Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid

NCT03188146 ·Status: COMPLETED

Pentoxifylline for Primary Biliary Cirrhosis

NCT01249092 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

NCT05014672 ·Status: COMPLETED ·Phase: PHASE2

A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis

NCT04004325 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.

NCT03776175 ·Status: COMPLETED ·Phase: PHASE2

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

NCT07282353 ·Status: RECRUITING ·Phase: PHASE3

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

NCT04650243 ·Status: RECRUITING ·Phase: PHASE4

Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

NCT04617561 ·Status: UNKNOWN ·Phase: PHASE4

Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis

NCT00406237 ·Status: COMPLETED ·Phase: PHASE1

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

NCT02308111 ·Status: TERMINATED ·Phase: PHASE4